Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Research Solutions, Inc.RSSS · Entity 6984 | Director | November 12, 2025 | November 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Research Solutions, Inc.
Report date November 12, 2025 · Filed November 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $3.07 · Expires 2035-11-11 | Direct | 50,000 |
Reported balance
After 2025-11-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-12 · Grant · Acquired 50,000 · Balance 50,000 F1: 1/3rd of the options vest on November 12, 2026 and 1/12th of the options vest on the last day of each quarter beginning December 31, 2026 until fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: 1/3rd of the options vest on November 12, 2026 and 1/12th of the options vest on the last day of each quarter beginning December 31, 2026 until fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2025 Filed Nov 15, 2025 01:00 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantOption to purchase common stock · Derivative | 50,000 | $0.00 Strike: $3.07 | $0.00 |
DisclosureSEC source: 0001104659-25-112823 · tm2531395-3_4seq1.xml · derivative · entry 1 Murphy Jeremy · CIK 0002001296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-11-11 F1 · derivative.exercise_date: 1/3rd of the options vest on November 12, 2026 and 1/12th of the options vest on the last day of each quarter beginning December 31, 2026 until fully vested. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 23:23 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantOption to purchase common stock · Derivative | 50,000 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001104659-24-117864 · tm2428421-1_4seq1.xml · derivative · entry 1 Murphy Jeremy · CIK 0002001296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-11-11 F1 · derivative.exercise_date: 1/3rd of the options vest on November 12, 2025 and 1/12th of the options vest on the last day of each quarter beginning December 31, 2025 until fully vested. Read SEC document |
| December 06, 2023 Filed Dec 9, 2023 02:12 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantOption to purchase common stock · Derivative | 60,137 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001104659-23-124807 · tm2332543-3_4seq1.xml · derivative · entry 1 Murphy Jeremy · CIK 0002001296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 60,137 shares Expires 2033-12-05 F1 · derivative.exercise_date: 1/3rd of the options vest on December 6, 2024 and 1/12th of the options vest on the last day of each quarter beginning December 31, 2024 until fully vested. Read SEC document |
| December 06, 2023 Filed Sep 24, 2024 17:50 UTC Amendment | Research Solutions, Inc. RSSS · Entity 6984 | GrantOption to purchase common stock · Derivative | 60,137 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001104659-24-102363 · tm2424616-6_4aseq1.xml · derivative · entry 1 Murphy Jeremy · CIK 0002001296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,137 Underlying: Common Stock · 60,137 shares Expires 2033-12-05 F1 · derivative.exercise_date: 1/3rd of the options vest on December 6, 2024 and 1/12th of the options vest on the last day of each quarter beginning December 31, 2024 until fully vested. F2 · balance_after: This amendment amends the Form 4 to correctly state the number of derivative securities beneficially owned following the reported transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.